GF
ITOS

Gabelli Funds’s iTeos Therapeutics ITOS Stock Holding History

Gabelli Funds’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-120,593
Closed -$1.2M – 1275
2025
Q2 		$1.2M Buy
+120,593
New +$971K 0.01% 855

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's ITOS Position: Q3 2025 in Review

Gabelli Funds sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 120,593 shares — an estimated $1.2M sold.

Gabelli Funds first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $1.2M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Gabelli Funds reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 120,593 iTeos Therapeutics shares in Q3 2025, an estimated $1.2M.
  • Gabelli Funds first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Gabelli Funds's iTeos Therapeutics position peaked at $1.2M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.